• 1
    Marshall B.J., Warren J.R. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 341: 13115.
  • 2
    Cover T., Blaser M.J. (2009) Helicobacter pylori in health and disease. Gastroenterology 136: 186373.
  • 3
    Chmiela M., Michetti P. (2006) Inflammation, immunity, vaccines for Helicobacter infection. Helicobacter 11 (suppl.1): 216.
  • 4
    Itoh T., Wakatsuki Y., Yoshida M., Usui T., Matsunaga Y., Kaneko S. (1999) The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection. J Gastroenterol 34: 56070.
  • 5
    Smythies L.E., Waites K.B., Lindsey J.R., Harris P.R., Ghiara P., Smith P.D. (2000) Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN- γ, gene-deficient mice. J Immunol 165: 10229.
  • 6
    Cooper M.A, Fehniger T.A., Caligiuri M.A. (2001) The biology of human natural killer cell subsets. Trends Immunol 22: 633.
  • 7
    Holck S., Norgaard A., Bennedsen M., Permin H., Norn S., Andersen L.P. (2003) Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunol Med Microbiol 36: 17580.
  • 8
    Mohammadi M.S., Czinn R., Redline R., Nedrud J. (1996) Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomach of mice. J Immunol 156: 472938.
  • 9
    Azem J., Svennerholm A.M., Lundin S. (2005) B cells pulsed with Helicobacter pylori antigens efficiently activate memory CD8+ T cells from H. pylori-infected individuals. Clin Immunol 118: 28491.
  • 10
    Asadullah K., Sterry W., Volk H.D. (2003). Interleukin-10. Therapy-review of a new approach. Pharmacological Reviews 55: 24169.
  • 11
    Mocellini S., Panelli M., Wang E., Rossi C.R., Pilati P., Nitti D., Lise M., Marincola F.M. (2004) IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes and Immunity 5: 62130.
  • 12
    O’Keeffe J., Gataley C.M., O’Donoghue Y., Zulquernain S.A., Stevens F.M. (2008) Natural killer cell receptor+ T-lymphocytes in normal and Helicobacter pylori-infected human gastric mucosa. Helicobacter 13: 5005.
  • 13
    Lindgren A., Yun C.H., Lundgren A., Sjöling A., Ohman L., Svennerholm A.M., Holmgren J., Lundin S.B. (2010) CD8- natural killer cells are greatly enriched in the human gastrointestinal tract and have the capacity to respond to bacteria. J Innate Immun. 2: 294302.
  • 14
    Andoniou C.E., Coudert J.D., Degli-Esposti M.A. (2008) Killers and beyond. NK-cell-mediated control of immune response. Eur J Immunol. 38: 293842.
  • 15
    Tarkkanen J., Kosunen T.U., Sakela E. (1993) Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of IFN- γ. Infect. Immun 61: 30126.
  • 16
    Knipp U., Kaup W., Opferkuch W. (1993) Immunosuppressive effects of Helicobacter pylori on human peripheral blood mononuclear cells. Med Microbiol Immunol 182: 638.
  • 17
    Paziak-Domańska B., Chmiela M., Jarosińska A., Rudnicka W. (2000) Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections. Cell Immunol 202: 1369.
  • 18
    Gebert B., Fischer W., Weiss E., Hoffman R., Haas R. (2003) Helicobacter pylori-vacuolating cytotoxin inhibits T lymphocyte activation. Science 301: 1099102.
  • 19
    Gerhard M., Schmees C., Voland N., Endres N., Sander M., Reindl W., Rad R., Oelsner M., Decker T., Mempel M., Hengst L., Prinz C. (2005) A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. Gastroenterology 128: 132739.
  • 20
    Torres V.J., VanCompernolle S.E., Sundrud M.S., Unutmaz D., Cover T.L. (2007) Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J Immunol 179: 543340.
  • 21
    Sundrud M.S., Torres V.J., Unutmaz D., Cover T.L. (2004) Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA 101: 772732.
  • 22
    Zabaleta J., McGee D.J., Zea A.H., Hernandez C.P., Rodrigez R.A., Sierra R.A., Correa P., Ochoa A.C. (2004) Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3ς). J Immunol 173: 58693.
  • 23
    Grębowska A., Moran A.P., Matusiak A., Bąk-Romaniszyn L., Czkwianianc E., Rechciński T., Walencka M., Płaneta-Małecka I., Rudnicka W., Chmiela M. (2008) Anti-phagocytic activity of Helicobacter pylori lipopolysaccharide (LPS) – possible modulation of the innate immune response to these bacteria. Pol J Microbiol 57: 18592.
  • 24
    Rudnicka K., Włodarczyk M., Moran A.P., Matusiak A., Walencka M., Rudnicka W., Chmiela M. (2009) Immunomodulatory activity of H. pylori LPS – possible reasons for chronic infections. Helicobacter 14: 357 (P04.10).
  • 25
    Bielański W., Konturek S.J. (1996) New approach to 13C-urea breath test capsule-based modification with low dose of 13C-urea in the diagnosis of Helicobacter pylori infection. J Physiol Pharmacol 47: 54553.
  • 26
    Rechciński T., Chmiela M., Małecka-Panas E., Płaneta-Małecka I., Rudnicka W. (1997) Serological indicators of Helicobacter pylori infection in adult dyspeptic patients and healthy blood donors. Microbiol Immunol 41: 38793.
  • 27
    Logan S.M., Trust T.J. (1983) Molecular identification of surface protein antigens of Campylobacter jejuni. Infect Immun 42: 67582.
  • 28
    Moran A.P., Helander I.M., Kosunen T.U. (1992) Compositional analysis of Helicobacter rough-form lipopolysaccharides. J Bacteriol 174: 13707.
  • 29
    Chmiela M., Czkwianianc E., Wadstrom T., Rudnicka W. (1997) Role of Helicobacter pylori surface structures in bacterial interaction with macrophages. Gut 40: 204.
  • 30
    Allen L.A.H. (2007) Phagocytosis and persistence of Helicobacter pylori. Cell Microbiol 9: 81728.
  • 31
    Grębowska A. Moran A.P., Bielański W., Matusiak A., Rechciński T., Rudnicka K., Baranowska A., Rudnicka W., Chmiela M. (2010) Helicobacter pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures. J Physiol Pharm 61: 43742.
  • 32
    Rudnicka W., Jarosinska A., Bąk-Romaniszyn L., Moran A.P., Płaneta-Małecka I., Wadstrom T., Chmiela M. (2003) Helicobacter pylori lipopolysaccharide in the IL-2 milieu activates lymphocytes from dyspeptic children. FEMS Immunol Med Microbiol 36: 1415
  • 33
    Guiney D.G., Hasegawa P., Cole S.P. (2003) Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect Immun 71: 41636.
  • 34
    De Jonge R., Kuipers E.J., Langeveld S.C.L., Loffeld R.J.L.F., Stoof J., van Vliet A.H.M., Kusters J.G. (2004) The Helicobacter pylori plasticity region locus jhp0947-jhp0949 is associated with duodenal ulcer disease and interleukin 12 production in monocyte cells. FEMS Immunol. Med Microbiol 41: 1617.
  • 35
    Hida N., Shimoyama T. Jr., Neville P., Dixon M.F., Axon A.T., Shimoyama Sr., Crabtree J.E. (1999) Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol 52: 65864.
  • 36
    Hafsi N.P., Voland S., Schwendy S., Rad R., Reindl W., Gerhard M., Prinz C. (2004) Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 173: 124957.
  • 37
    Nakano M., Kirikae T., Nitta T. (2000) Effects of lipopolysaccharide on T cells. In: Brade H., Opal S.M., Vogel S.N., Morrison D.C., Dekker M., eds. Endotoxin In Health and Disease. New York : Marchel Dekker. Inc., pp. 643650.
  • 38
    Cheol H.Y., Lundgren A., Azem J., Sjoling A., Holmgren J., Svennerholm A.M., Lundin B.S. (2005) Natural killer cells and Helicobacter pylori infection: bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production. Infect Immun 73: 148290.
  • 39
    De Blaker-Hohe D’Anna F., Yamaguchi A., Cheng-Rong Yu., Horvath-Arcidiacano J., Bloom E. (1995) IL-12 synergizes with IL-2 to induce lymphokine activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol 165: 334.
  • 40
    Kao J.Y., Rathinavelu S., Eaton K.A., Bai L., Zavros Y., Takami M., Pierzchała A., Merchant J.L. (2006) Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanizm of ineffective host defense. Am J Physiol Gastrointest Liver Physiol 291: G7381.
  • 41
    Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O’Garra A. (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 381522.
  • 42
    Wittmann M., Larsson V.A., Schmidt P., Bergmann G., Kapp A., Werfel  . (1999) Suppression of interleukin-IL12 production by human monocytes after preincubation with lipopolysaccharide. Immunol 94: 171726.
  • 43
    Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. (2004) Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 202: 13956.
  • 44
    Mohammadi M.S., Nedrud J., Redline R., Lycke N., Czinn S.J. (1997) Murine CD4 T-cell response to Helicobacter infection: Th1 cells enhance gastritis and Th2 cells reduce bacterial load. Gastroeterology 113: 184857.
  • 45
    Yun Ch.H., Lundgren A., Azem J., Sjoling A., Holmgren J., Svennerholm A.M., Lundin S. (2005) Natural killer cells and Helicobacter pylori infection bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production. Infect Immun 73: 148290.
  • 46
    Pellicano A., Sebkova L., Monteleone  , Guarnieri G., Imeneo M., Pallone F., Luzza F. (2007) Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa. Infect Immun 75: 17381744.
  • 47
    Chocchi K., Ichikura T., Kinoshita M., Majima T., Shinomiya N., Tsujimoto H., Kawabata T., Sugasawa H., Ono S., Seki S., Mochizuki H. (2008) Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide -Toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin Cancer Res 14: 290917.
  • 48
    Szkaradkiewicz A., Karpiński T.M., Drews M., Borejsza-Wysocki M., Majewski P., Andrzejewska E. (2010) Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-β1) in patients with gastric cancer. J Biomed Biotechnol 2010: 17.
  • 49
    Grębowska A., Moran A.P., Czkwianianc E., Bąk-Romaniszyn L., Płaneta-Małecka I., Rudnicka W., Chmiela M. (2004) A modulation of macrophage response to H. pylori LPS with or without Lewis XY determinants. Helicobacter 9: 523 (05.16).
  • 50
    Bergman M.P., Engering A., Smith H.H., van Villet S.J., van Bodergraven A.A., Wirth H.P., Kapsenberg M.L., Vandenbroucke-Grauls C.M., van Kooy K., Appelmelk B.J. (2004) Helicobacter pylori modulates T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 200: 97990.